Detalhe da pesquisa
1.
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.
Medicine (Baltimore)
; 95(6): e2673, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26871794